| # | Drug | Count |
|---|---|---|
| 0 | PREDNISOLONE | 8 |
| 1 | PREDNISOLONE ORAL | 8 |
| 2 | PREDNISOLONE ORAL SOLUTION | 8 |
| 3 | MYCOPHENOLATE MOFETIL | 6 |
| 4 | IVERMECTIN | 5 |
| 5 | RASAGILINE MESYLATE | 4 |
| 6 | DUPILUMAB | 3 |
| 7 | RASAGILINE | 3 |
| 8 | TACROLIMUS | 3 |
| 9 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MEBENDAZOLE | 1 | 0.0013 |
| 1 | IVERMECTIN | 5 | 0.0011 |
| 2 | PLERIXAFOR | 1 | 0.0007 |
| 3 | RASAGILINE MESYLATE | 4 | 0.0004 |
| 4 | CEFOTAXIME INJECTION | 1 | 0.0002 |
| 5 | ROPINIROLE | 2 | 0.0001 |
| 6 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 1 | 0.0001 |
| 7 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 1 | 0.0001 |
| 8 | GRANISETRON HYDROCHLORIDE | 1 | 0.0001 |
| 9 | GRANISETRON | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 10 |
| 1 | Antiparasitic [EPC] | 5 |
| 2 | Pediculicide [EPC] | 5 |
| 3 | Interleukin-4 Receptor alpha Antagonist [EPC] | 3 |
| 4 | Nonergot Dopamine Agonist [EPC] | 2 |
| 5 | Anthelmintic [EPC] | 1 |
| 6 | Anti-epileptic Agent [EPC] | 1 |
| 7 | Atypical Antipsychotic [EPC] | 1 |
| 8 | Cytochrome P450 3A Inhibitor [EPC] | 1 |
| 9 | Factor Xa Inhibitor [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antiparasitic [EPC] | 5 | 0.0011 |
| 1 | Pediculicide [EPC] | 5 | 0.0011 |
| 2 | Hematopoietic Stem Cell Mobilizer [EPC] | 1 | 0.0007 |
| 3 | Anthelmintic [EPC] | 1 | 0.0003 |
| 4 | Nonergot Dopamine Agonist [EPC] | 2 | 0.0001 |
| 5 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Parathyroid Hormone-Related Peptide Analog [EPC] | 1 | 0.0000 |
| 7 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 8 | Cytochrome P450 3A Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Tetracycline-class Drug [EPC] | 1 | 0.0000 |